TR199700916T1 - Oral ispençiyari dozaj formlari. - Google Patents
Oral ispençiyari dozaj formlari.Info
- Publication number
- TR199700916T1 TR199700916T1 TR97/00916T TR9700916T TR199700916T1 TR 199700916 T1 TR199700916 T1 TR 199700916T1 TR 97/00916 T TR97/00916 T TR 97/00916T TR 9700916 T TR9700916 T TR 9700916T TR 199700916 T1 TR199700916 T1 TR 199700916T1
- Authority
- TR
- Turkey
- Prior art keywords
- dosage
- proton pump
- pump inhibitor
- iyari
- formlar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sabit bir formülasyon içinde bir asit duyarli proton pompa inhibitörü ve bir ya da birkaç antasit maddesi ya da bir alginat ihtiva eden bir oral ispençiyari dozaj formu olup, bu formda proton pompa inhibitörü proton pompa inhibitörü ve enterik kaplama arasinda bir enterik kaplama tabakasi ve istege göre bir ayirici tabaka ile korunmaktadir. Sabit formülasyon çok katmanli tabletler, küçük torbalar ya da çoklu birim taleplenmis dozaj formlari seklindedir. Çoklu birim dozaj formu tercih edilmektedir. Yeni sabit formülasyon özellikle mide eksimesi gibi hazimsizlikla ilgili rahatsizliklarin tedavisinde kullanislidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9600071A SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | New oral formulation of two active ingredients I |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199700916T1 true TR199700916T1 (tr) | 1997-12-21 |
Family
ID=20400969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR97/00916T TR199700916T1 (tr) | 1996-01-08 | 1996-12-20 | Oral ispençiyari dozaj formlari. |
Country Status (35)
Country | Link |
---|---|
US (1) | US6183776B1 (tr) |
EP (1) | EP0813424B2 (tr) |
JP (1) | JPH11501950A (tr) |
KR (1) | KR100490075B1 (tr) |
CN (1) | CN1080125C (tr) |
AR (1) | AR005281A1 (tr) |
AT (1) | ATE228009T1 (tr) |
AU (1) | AU712669B2 (tr) |
BR (1) | BR9607350B1 (tr) |
CA (1) | CA2213996C (tr) |
CZ (1) | CZ293583B6 (tr) |
DE (1) | DE69624907T3 (tr) |
DK (1) | DK0813424T4 (tr) |
EE (1) | EE04002B1 (tr) |
EG (1) | EG23821A (tr) |
ES (1) | ES2185817T5 (tr) |
HK (2) | HK1001763A1 (tr) |
HU (1) | HU229153B1 (tr) |
IL (1) | IL121651A (tr) |
IS (1) | IS2716B (tr) |
MX (1) | MX9706785A (tr) |
MY (1) | MY116091A (tr) |
NO (1) | NO326656B1 (tr) |
NZ (1) | NZ325977A (tr) |
PL (1) | PL187075B1 (tr) |
PT (1) | PT813424E (tr) |
RU (1) | RU2179453C2 (tr) |
SA (1) | SA97170553B1 (tr) |
SE (1) | SE9600071D0 (tr) |
SK (1) | SK283695B6 (tr) |
TR (1) | TR199700916T1 (tr) |
TW (1) | TW464514B (tr) |
UA (1) | UA45392C2 (tr) |
WO (1) | WO1997025066A1 (tr) |
ZA (1) | ZA9610935B (tr) |
Families Citing this family (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US20050054682A1 (en) * | 1996-01-04 | 2005-03-10 | Phillips Jeffrey O. | Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
AU5446798A (en) * | 1996-11-27 | 1998-06-22 | Procter & Gamble Company, The | Compositions and methods for the treatment of gastrointestinal disorders |
MX9703918A (es) * | 1997-05-28 | 1998-11-30 | J Marshall M D Barry | Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior. |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
WO1999010000A1 (en) * | 1997-08-25 | 1999-03-04 | The Procter & Gamble Company | Combined preparations for treating upper gastrointestinal tract distress |
SI1037607T1 (en) * | 1997-12-08 | 2004-08-31 | Altana Pharma Ag | Novel suppository form comprising an acid-labile active compound |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
FR2774906B1 (fr) * | 1998-02-13 | 2000-05-12 | Rhodia Chimie Sa | Systeme d'encapsulation a coeur organique et a ecorce minerale a base d'hydroxycarbonate d'aluminium et son procede de preparation |
AU3731699A (en) * | 1998-05-18 | 1999-12-06 | Takeda Chemical Industries Ltd. | Orally disintegrable tablets |
US7122207B2 (en) | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
AU4802099A (en) | 1998-07-28 | 2000-02-21 | Takeda Chemical Industries Ltd. | Rapidly disintegrable solid preparation |
SE9803772D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
CA2367669A1 (en) * | 1999-03-29 | 2000-10-05 | American Home Products Corporation | Coating system |
AU6087100A (en) * | 1999-07-12 | 2001-01-30 | Smithkline Beecham Corporation | Heartburn treatment |
RU2259828C2 (ru) | 1999-10-20 | 2005-09-10 | Эйсай Ко., Лтд. | Способы стабилизации соединений на основе бензимидазола |
US20040191276A1 (en) * | 1999-11-30 | 2004-09-30 | Cutispharma, Inc. | Compositions and kits for compounding pharmaceuticals |
WO2002026210A2 (en) * | 2000-09-29 | 2002-04-04 | Geneva Pharmaceuticals Inc. | Proton pump inhibitor formulation |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
NZ530511A (en) * | 2001-07-16 | 2005-06-24 | Astrazeneca Ab | A tablet for treating disorders of the gastrointestinal tract comprising a proton pump inhibitor and at least one antacid that has a barrier layer to cover an enteric coating film |
AR036354A1 (es) * | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | Preparacion solida |
CN1638740A (zh) * | 2001-09-28 | 2005-07-13 | 麦克内尔-Ppc股份有限公司 | 释出得到修饰的剂型 |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US7008777B2 (en) | 2001-10-15 | 2006-03-07 | Barry J. Marshall | System for the detection of urease and method for using same |
CA2472103A1 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
KR100479637B1 (ko) * | 2002-02-01 | 2005-03-31 | 한국화학연구원 | 란소프라졸을 함유하는 경구제제 및 그의 제조방법 |
CO5400144A1 (es) * | 2002-03-11 | 2004-05-31 | Novartis Ag | Compuestos organicos |
ATE419840T1 (de) | 2002-04-09 | 2009-01-15 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
US20040081700A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Dose titratable liquid dosage forms of acid labile drugs |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
US6663892B1 (en) * | 2002-08-19 | 2003-12-16 | L. Perrigo Company | Multiple portion tablet |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
EP1552833B1 (en) | 2002-10-16 | 2016-12-28 | Takeda Pharmaceutical Company Limited | Process for producing an amorphous optically active isomer of lansoprazole |
SE0203065D0 (sv) * | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US7258981B2 (en) * | 2003-01-24 | 2007-08-21 | Clontech Laboratories, Inc. | Sensitive proteasome sensor constructs and methods for their design and use |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
US20040248942A1 (en) * | 2003-02-20 | 2004-12-09 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
EP1759692A3 (en) * | 2003-03-10 | 2007-09-12 | Novartis AG | Taste-masked solid veterinary compositions |
CN100342860C (zh) * | 2003-03-18 | 2007-10-17 | 兴和株式会社 | 抗酸剂组合物 |
WO2004112756A1 (en) | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
AR045062A1 (es) * | 2003-07-18 | 2005-10-12 | Santarus Inc | Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas |
EP1648417A4 (en) * | 2003-07-18 | 2010-01-20 | Santarus Inc | PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF GASTROINTESTINAL ACIDITY RELATED DISORDERS |
JPWO2005011637A1 (ja) * | 2003-08-04 | 2006-09-14 | エーザイ株式会社 | 用時分散型製剤 |
US7282050B2 (en) * | 2003-10-31 | 2007-10-16 | Medtronic, Inc. | Ablation of exterior of stomach to treat obesity |
US7252665B2 (en) * | 2003-10-31 | 2007-08-07 | Medtronic, Inc | Ablation of stomach lining to reduce stomach acid secretion |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
US7041124B2 (en) * | 2003-12-23 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | System and method for providing therapy to a portion of a body |
GB0403165D0 (en) * | 2004-02-12 | 2004-03-17 | Ct | Novel uses for proton pump inhibitors |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20070224269A1 (en) * | 2004-06-10 | 2007-09-27 | Rubino Orapin P | Controlled Release Pharmaceutical Formulation |
US20050281876A1 (en) * | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
GB2418854B (en) * | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
US8747895B2 (en) * | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US20060165797A1 (en) * | 2005-01-12 | 2006-07-27 | Pozen Inc. | Dosage form for treating gastrointestinal disorders |
US8673352B2 (en) * | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
SE530605C2 (sv) * | 2005-09-29 | 2008-07-15 | Barbara Nelson | Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
RU2496480C2 (ru) * | 2005-12-28 | 2013-10-27 | Такеда Фармасьютикал Компани Лимитед | Твердый препарат с контролируемым высвобождением |
CA2648280C (en) * | 2006-04-03 | 2014-03-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
US20090068263A1 (en) * | 2006-04-20 | 2009-03-12 | Themis Laboratories Private Limited | Multiple unit compositions |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US20100297226A1 (en) * | 2006-06-01 | 2010-11-25 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
AR056062A1 (es) * | 2006-06-05 | 2007-09-19 | Bago Sa Labor | Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion |
CN101120930B (zh) * | 2006-08-11 | 2010-09-29 | 石药集团中奇制药技术(石家庄)有限公司 | 一种奥美拉唑组合物及其制备方法 |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
CN101259140B (zh) * | 2007-03-08 | 2012-08-22 | 重庆北碚现代应用药物研究所 | 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法 |
CA2687130C (en) * | 2007-05-07 | 2017-10-03 | Evonik Roehm Gmbh | Solid dosage forms comprising an enteric coating with accelerated drug release |
EP2044929A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Oral fast distintegrating tablets |
ITFI20070253A1 (it) * | 2007-11-09 | 2009-05-10 | Valpharma Internat S P A | Formulazioni farmaceutiche per la somministrazione di ipp. |
JP2011512416A (ja) | 2008-02-20 | 2011-04-21 | ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ | オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法 |
EP2127643A1 (de) * | 2008-05-30 | 2009-12-02 | Bayer Schering Pharma Aktiengesellschaft | Orale Pelletformulierungen mit zeitversetzter Wirkstofffreigabe |
EA201100313A1 (ru) | 2008-09-09 | 2011-10-31 | Астразенека Аб | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом |
WO2010038241A2 (en) * | 2008-09-30 | 2010-04-08 | Panacea Biotec Limited | Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid |
JP2012072061A (ja) * | 2009-01-29 | 2012-04-12 | Eisai R & D Management Co Ltd | 新規組成物 |
EP2445499A4 (en) | 2009-06-25 | 2013-02-27 | Astrazeneca Ab | METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE |
CA2766524A1 (en) * | 2009-06-25 | 2010-12-29 | Pozen Inc. | Method for treating a patient in need of aspirin therapy |
TWI471146B (zh) | 2009-12-02 | 2015-02-01 | Aptalis Pharma Ltd | 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物 |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
US20120294937A1 (en) | 2009-12-29 | 2012-11-22 | Novartis Ag | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
AR079862A1 (es) * | 2010-01-08 | 2012-02-22 | Eurand Inc | Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion |
EP2560732A2 (en) | 2010-04-23 | 2013-02-27 | S-Biotek Holding ApS | A solid pharmaceutical composition for neutralizing stomach acid |
WO2013101897A2 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
US20140127296A1 (en) * | 2012-11-05 | 2014-05-08 | Kenneth John Tibbs | Pharmaceutical preparation and method for treatment of diabetes |
US20150238514A1 (en) * | 2014-02-21 | 2015-08-27 | William Armstrong | Protective Supplement Configuration |
EP3288556A4 (en) * | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
SG11201809555QA (en) * | 2016-04-29 | 2018-11-29 | Alan Thompson | Veterinary composition |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
TR201723199A2 (tr) * | 2017-12-30 | 2019-07-22 | Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi | Yeni farmasötik bileşimler. |
KR102080023B1 (ko) | 2018-01-29 | 2020-02-21 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 |
KR102006777B1 (ko) | 2018-01-29 | 2019-10-08 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제 |
US20220233514A1 (en) * | 2018-08-23 | 2022-07-28 | Chong Kun Dang Pharmaceutical Corp. | Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate |
WO2021075926A1 (ko) * | 2019-10-17 | 2021-04-22 | 한미약품 주식회사 | 프로톤 펌프 저해제 및 제산제를 포함하는 약학적 조성물 |
BR112022014430A2 (pt) * | 2020-01-23 | 2022-09-13 | Hanmi Pharm Ind Co Ltd | Formulação farmacêutica composta |
KR102531045B1 (ko) * | 2020-01-23 | 2023-05-11 | 한미약품 주식회사 | 프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 |
KR102608889B1 (ko) * | 2020-07-14 | 2023-12-04 | 한미약품 주식회사 | 프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 및 그의 제조방법 |
WO2022103233A1 (ko) * | 2020-11-13 | 2022-05-19 | (주)휴온스 | 라베프라졸 및 제산제를 포함하는 약제학적 복합제제 및 이의 제조방법 |
CN114569579B (zh) | 2020-12-02 | 2023-10-31 | 丽珠医药集团股份有限公司 | 肠溶微丸、其制备方法和包含它的制剂 |
KR20230097346A (ko) * | 2021-12-24 | 2023-07-03 | 한미약품 주식회사 | 프로톤 펌프 저해제 및 제산제를 포함하는 경구용 복합정제의 제조방법 및 이에 의해 제조된 경구용 복합정제 |
KR102553713B1 (ko) * | 2022-11-18 | 2023-07-10 | 고덕상 | 미네랄 촉매제를 이용한 양식어류사료 제조방법 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535031A (en) | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
JPS5598120A (en) | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
FR2471186A1 (fr) | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
US4340582A (en) | 1981-01-15 | 1982-07-20 | Abbott Laboratories | Erythromycin base tablets |
US4377568A (en) | 1981-08-12 | 1983-03-22 | Merck Sharp & Dohme (I.A.) Corp. | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same |
DK150008C (da) | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
JPS5973529A (ja) | 1982-10-12 | 1984-04-25 | Sankyo Co Ltd | 被覆固形製剤の製造法 |
US4525339A (en) | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
US4518433A (en) | 1982-11-08 | 1985-05-21 | Fmc Corporation | Enteric coating for pharmaceutical dosage forms |
GB2132887A (en) | 1982-11-15 | 1984-07-18 | Procter & Gamble | Enteric-coated anti-inflammatory compositions |
US4556552A (en) | 1983-09-19 | 1985-12-03 | Colorcon, Inc. | Enteric film-coating compositions |
DE3586600T2 (de) | 1984-02-10 | 1993-02-18 | Benzon Pharma As | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. |
US4568560A (en) | 1984-03-16 | 1986-02-04 | Warner-Lambert Company | Encapsulated fragrances and flavors and process therefor |
SE450087B (sv) | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
WO1987004077A1 (en) | 1986-01-03 | 1987-07-16 | The University Of Melbourne | Gastro-oesophageal reflux composition |
US5112813A (en) | 1986-03-07 | 1992-05-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Process for the preparation of a viscosity-stable antacid composition |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DK179687D0 (da) | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
KR960011236B1 (ko) † | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
ATE73328T1 (de) † | 1987-05-08 | 1992-03-15 | Smith Kline French Lab | Pharmazeutische zusammensetzungen. |
GB8809421D0 (en) | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
CH679373A5 (tr) | 1988-09-20 | 1992-02-14 | Glaxo Group Ltd | |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
US5026559A (en) | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
DE4023028A1 (de) * | 1990-07-20 | 1992-01-23 | Hoechst Ag | Ferroelektrische fluessigkristalline si-enthaltende copolymere, ein verfahren zu ihrer herstellung, mischungen dieser copolymere mit niedermolekularen fluessigkristallen und die verwendung in elektrooptischen bauteilen |
US5244670A (en) * | 1991-04-04 | 1993-09-14 | The Procter & Gamble Company | Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
IT1251153B (it) | 1991-08-06 | 1995-05-04 | Vectorpharma Int | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
JP3142919B2 (ja) | 1991-11-06 | 2001-03-07 | 旭化成株式会社 | セルロース誘導体ラテックス及びその製法 |
US5160742A (en) | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
US5229137A (en) † | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
US5447918A (en) | 1992-07-27 | 1995-09-05 | Mccullough; Ricky W. | Gastrointestinal anti-irritant composition comprising sucralfate and methods of use |
ES2173096T3 (es) | 1992-08-05 | 2002-10-16 | Faulding F H & Co Ltd | Composicion farmaceutica peletizada. |
US5330759A (en) | 1992-08-26 | 1994-07-19 | Sterling Winthrop Inc. | Enteric coated soft capsules and method of preparation thereof |
CA2110313C (en) † | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
CA2166731A1 (en) | 1993-07-06 | 1995-01-19 | Robert T. Sims | H2 antagonist-alginate-antacid combinations |
WO1995001780A1 (en) | 1993-07-06 | 1995-01-19 | Merck & Co., Inc. | H2 antagonist-alginate combinations |
AU7833194A (en) | 1993-09-20 | 1995-04-10 | Procter & Gamble Company, The | Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection |
JP3017906B2 (ja) | 1993-10-08 | 2000-03-13 | 信越化学工業株式会社 | 腸溶性コーティング剤分散液 |
ATE219931T1 (de) | 1993-10-12 | 2002-07-15 | Mitsubishi Pharma Corp | Darmlösliche grannulatkörner enthaltende tablette |
GB2285989A (en) | 1994-01-28 | 1995-08-02 | Merck Frosst Canada Inc | Aqueous formulations for enteric coatings |
AUPM596894A0 (en) | 1994-05-30 | 1994-06-23 | Hybrid Scientific Pty Ltd | Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders |
SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
CA2170647C (en) | 1994-07-08 | 2001-03-13 | Pontus John Arvid Bergstrand | Multiple unit tableted dosage form i |
AUPM695294A0 (en) | 1994-07-20 | 1994-08-11 | Borody, Thomas Julius | Improved combination therapy dose unit |
DE69614097T2 (de) | 1995-03-17 | 2002-03-14 | Boots Co Ltd | Flüssige pharmazeutische zusammensetzungen mit pektin |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
AU5446798A (en) | 1996-11-27 | 1998-06-22 | Procter & Gamble Company, The | Compositions and methods for the treatment of gastrointestinal disorders |
-
1996
- 1996-01-08 SE SE9600071A patent/SE9600071D0/xx unknown
- 1996-12-20 CN CN96193594A patent/CN1080125C/zh not_active Expired - Fee Related
- 1996-12-20 CA CA002213996A patent/CA2213996C/en not_active Expired - Fee Related
- 1996-12-20 WO PCT/SE1996/001737 patent/WO1997025066A1/en active IP Right Grant
- 1996-12-20 US US08/750,934 patent/US6183776B1/en not_active Expired - Lifetime
- 1996-12-20 DK DK96944726T patent/DK0813424T4/da active
- 1996-12-20 MX MX9706785A patent/MX9706785A/es not_active IP Right Cessation
- 1996-12-20 RU RU97116726/14A patent/RU2179453C2/ru not_active IP Right Cessation
- 1996-12-20 EE EE9700192A patent/EE04002B1/xx not_active IP Right Cessation
- 1996-12-20 NZ NZ325977A patent/NZ325977A/xx not_active IP Right Cessation
- 1996-12-20 AT AT96944726T patent/ATE228009T1/de active
- 1996-12-20 JP JP9525131A patent/JPH11501950A/ja active Pending
- 1996-12-20 DE DE69624907T patent/DE69624907T3/de not_active Expired - Lifetime
- 1996-12-20 SK SK1169-97A patent/SK283695B6/sk not_active IP Right Cessation
- 1996-12-20 IL IL12165196A patent/IL121651A/xx not_active IP Right Cessation
- 1996-12-20 PL PL96322175A patent/PL187075B1/pl not_active IP Right Cessation
- 1996-12-20 EP EP96944726A patent/EP0813424B2/en not_active Expired - Lifetime
- 1996-12-20 ES ES96944726T patent/ES2185817T5/es not_active Expired - Lifetime
- 1996-12-20 UA UA97104949A patent/UA45392C2/uk unknown
- 1996-12-20 HU HU9904024A patent/HU229153B1/hu not_active IP Right Cessation
- 1996-12-20 TR TR97/00916T patent/TR199700916T1/tr unknown
- 1996-12-20 KR KR1019970706236A patent/KR100490075B1/ko not_active IP Right Cessation
- 1996-12-20 PT PT96944726T patent/PT813424E/pt unknown
- 1996-12-20 AU AU13241/97A patent/AU712669B2/en not_active Ceased
- 1996-12-20 CZ CZ19972747A patent/CZ293583B6/cs not_active IP Right Cessation
- 1996-12-20 BR BRPI9607350-0A patent/BR9607350B1/pt not_active IP Right Cessation
- 1996-12-26 AR ARP960105899A patent/AR005281A1/es not_active Application Discontinuation
- 1996-12-27 TW TW085116139A patent/TW464514B/zh not_active IP Right Cessation
- 1996-12-30 ZA ZA9610935A patent/ZA9610935B/xx unknown
-
1997
- 1997-01-07 MY MYPI97000065A patent/MY116091A/en unknown
- 1997-01-07 EG EG1897A patent/EG23821A/xx active
- 1997-01-15 SA SA97170553A patent/SA97170553B1/ar unknown
- 1997-08-20 IS IS4548A patent/IS2716B/is unknown
- 1997-09-04 NO NO19974071A patent/NO326656B1/no not_active IP Right Cessation
-
1998
- 1998-02-05 HK HK98100847A patent/HK1001763A1/xx not_active IP Right Cessation
- 1998-11-06 HK HK98111792A patent/HK1017992A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199700916T1 (tr) | Oral ispençiyari dozaj formlari. | |
TR199700915T1 (tr) | Oral ispençiyari dozaj formlari. | |
TR199700917T1 (tr) | Oral farmasötik dozaj formlari. | |
TR199701117T1 (tr) | Proton-ifrazatini -önleyici maddeler içeren farmasötik bilesim. | |
MX9604354A (es) | Nueva forma de dosis farmaceutica oral. | |
TR199701030T1 (tr) | Seçilmis lanthanum karbonat hidratlari içeren farmasötik terkip. | |
TR199800902T2 (tr) | Ecza formülasyonlari. | |
DE69701532T2 (de) | Orale zusammensetzung gegen zahnbelag | |
NO20024733D0 (no) | Hydrofile molekyl¶rdisperse lösninger av karvedilol | |
TR200003176T2 (tr) | Mide asit salgısını inhibe eden imidazo piridin türevleri | |
TR200002860T2 (tr) | Bir antiviral benzimidazol terkibin yeni kristal formları. | |
TR199901411T2 (tr) | Analjezik etkili yeni bilesimler. | |
TR200001982T2 (tr) | Farmasötik vurulu salınımlı oral dozaj şekli. | |
TR200103693T2 (tr) | Yeni formülasyon | |
TR200003808T2 (tr) | Bir cox-2 inhibitörü içeren farmasötik kombinasyon | |
TR200200982T2 (tr) | Farmasötik bileşim terkipleri. | |
TR199901972T1 (tr) | Masaj ve cilt vakum cihazi. | |
DE59812646D1 (de) | Laminare Arzneiform | |
DK1332757T3 (da) | Komprimeret tabletformulering indeholdende efavirenz | |
TR200000635T2 (tr) | Levosimendan'ın oral kompozisyonları. | |
RU99118887A (ru) | Применение ингибиторов желудочно-кишечной липазы | |
IT1275816B1 (it) | Composizioni farmaceutiche solide per uso vaginale | |
TR199802351T2 (tr) | Topikal kullanim için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bilesimi. | |
TR199701121T1 (tr) | Benazepril veya benazeprilat ve valsartan içeren kombinasyon bilesimleri. | |
TR199800714T2 (tr) | Yeni [(3-Alkoksi-fenoksi)-etil]-dialkilamin türevleri. |